BioScrip Inc. (BIOS) was a big mover last session, as the company saw its shares rise by over 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company, as the stock is now down 6% in the past one-month time frame.
In the past 30-day time frame, the company has seen three negative estimate revisions and its Zacks Consensus Estimate has nudged down, suggesting trouble down the road. So make sure to keep an eye on this stock, going forward, to see if this recent move higher can last.
BioScrip currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked drug retailers include Rite Aid Corporation (RAD) and Herbalife Ltd. (HLF). While Reit Aid carries a Zacks Rank #1 (Strong Buy), Herbalife holds a Zacks Rank #2 (Buy). Another stock worth considering in the broader biopharma sector is Jazz Pharmaceuticals Public Limited Company (JAZZ) carrying a Zacks Rank #1.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment